Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.

This study tested whether an investigational drug called 611 could help control moderate-to-severe chronic obstructive pulmonary disease (COPD) in Chinese adults. 142 participants who were already on standard COPD medications received either 611 or a placebo for 16 weeks. Researc…

This study tested a new injectable drug called 611 in Chinese adults with moderate to severe atopic dermatitis (eczema). The goal was to see if the drug could safely reduce the severity of skin rashes and itching over a year of treatment. Researchers compared the drug's effects a…

This study tested if a new eye injection called 601 works as well as or better than the standard drug (ranibizumab) for treating vision loss caused by fluid buildup from a blocked retinal vein (BRVO). 351 adults with this condition received monthly injections of one of the two dr…